Felix Bock Selected Research

GS 101

9/2014	Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study.
7/2011	Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
9/2009	GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Felix Bock Research Topics

Disease

27	Corneal Neovascularization 06/2021 - 06/2007
11	Inflammation (Inflammations) 01/2021 - 06/2007
6	Neoplasms (Cancer) 01/2022 - 06/2007
5	Neoplasm Metastasis (Metastasis) 02/2015 - 06/2007
3	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021 - 05/2013
3	Corneal Diseases (Corneal Disease) 01/2019 - 10/2009
2	Melanoma (Melanoma, Malignant) 01/2022 - 05/2013
2	Limbal Stem Cell Deficiency 12/2019 - 02/2008
1	Disease Progression 01/2021
1	Wounds and Injuries (Trauma) 10/2020
1	Macular Edema 07/2020
1	Endometrial Neoplasms (Endometrial Cancer) 10/2018
1	Cataract (Cataracts) 07/2017
1	Corneal Edema 01/2017
1	Necrosis 01/2017
1	Hypersensitivity (Allergy) 05/2015
1	Eye Diseases (Eye Disease) 05/2015
1	Keratitis 09/2014
1	Glaucoma 08/2013
1	Blindness (Hysterical Blindness) 05/2013
1	Abscess 01/2012
1	Acanthamoeba Keratitis 01/2012
1	AIDS-Related Complex (ARC) 05/2008
1	Chemical Burns (Chemical Burn) 02/2008

Drug/Important Bio-Agent (IBA)

8	Ophthalmic Solutions (Eye Drops)IBA 09/2014 - 02/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 05/2009
5	Bevacizumab (Avastin)FDA Link 08/2012 - 06/2007
3	Thrombospondin 1IBA 09/2015 - 10/2010
3	GS 101IBA 09/2014 - 09/2009
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2016
2	Vascular Endothelial Growth Factor CIBA 01/2016 - 07/2010
2	Antisense OligonucleotidesIBA 09/2014 - 09/2009
2	Insulin Receptor Substrate ProteinsIBA 09/2014 - 09/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	resiniferatoxinIBA 01/2021
1	Fluorescein (Funduscein)FDA LinkGeneric 10/2020
1	perfluorohexyl-octanIBA 10/2020
1	Green OrIBA 07/2020
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2019
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2018
1	Nylons (Nylon)IBA 11/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	CytokinesIBA 01/2016
1	Muramidase (Lysozyme)IBA 01/2016
1	OvalbuminIBA 05/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2014
1	pegaptanib (Macugen)FDA Link 06/2014
1	Ranibizumab (Lucentis)FDA Link 03/2014
1	tafluprostIBA 08/2013
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 08/2013
1	prednisolone acetate FDA LinkGeneric 04/2011
1	Fluorometholone (FML)FDA Link 04/2011
1	dexamethasone 21-phosphate FDA LinkGeneric 04/2011
1	CollagenIBA 01/2011
1	Tyrosine Kinase InhibitorsIBA 05/2008
1	Angiogenesis InhibitorsIBA 01/2008

Therapy/Procedure

16	Sutures (Suture) 10/2020 - 06/2007
11	Corneal Transplantation (Keratoplasty) 06/2021 - 01/2008
7	Therapeutics 01/2022 - 02/2008
3	Penetrating Keratoplasty 02/2021 - 06/2007
3	Transplantation 09/2014 - 09/2009
2	Slit Lamp 02/2021 - 07/2017
2	Organ Transplantation 01/2011 - 07/2010
2	Off-Label Use 10/2009 - 01/2008
1	Cell Transplantation 01/2021
1	Debridement 10/2020
1	Stem Cell Transplantation 12/2019
1	Adjuvant Chemoradiotherapy 10/2018
1	Diathermy 08/2012